Sodium Citrate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09154 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 41 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | papillary conjunctivitis | KG + DL |
| 2 | nasal cavity disease | KG + DL |
| 3 | acute laryngopharyngitis | KG + DL |
| 4 | stomach disease | KG + DL |
| 5 | postgastrectomy syndrome | KG + DL |
| 6 | gastroduodenitis | KG + DL |
| 7 | familial visceral myopathy | KG + DL |
| 8 | rosacea conjunctivitis | KG + DL |
| 9 | allergic urticaria | KG + DL |
| 10 | intestinal obstruction | KG + DL |
| 11 | urticaria (disease) | KG + DL |
| 12 | neuronal intestinal dysplasia, type B | KG + DL |
| 13 | myopathic intestinal pseudoobstruction | KG + DL |
| 14 | unclassified intestinal pseudoobstruction | KG + DL |
| 15 | cold urticaria | KG + DL |
| 16 | peptic ulcer perforation | KG + DL |
| 17 | gastrojejunal ulcer | KG + DL |
| 18 | exercise-induced malignant hyperthermia | KG + DL |
| 19 | intestinal motility disease | KG + DL |
| 20 | faucial diphtheria | KG + DL |
| 21 | cervical disc degenerative disorder | KG + DL |
| 22 | visceral myopathy | KG + DL |
| 23 | angioedema | KG + DL |
| 24 | esophageal ulcer | KG + DL |
| 25 | viral conjunctivitis | KG + DL |
| 26 | obsolete CFM1 | KG + DL |
| 27 | paralytic ileus (disease) | KG + DL |
| 28 | ulcer disease | KG + DL |
| 29 | esophageal atresia (disease) | KG + DL |
| 30 | esophageal leukoplakia (disease) | KG + DL |
| 31 | nutritional biotin deficiency | KG + DL |
| 32 | esophageal diverticulosis | KG + DL |
| 33 | congenital short bowel syndrome 1 | KG + DL |
| 34 | atopic conjunctivitis | KG + DL |
| 35 | esophageal tuberculosis | KG + DL |
| 36 | esophageal malformation | KG + DL |
| 37 | anorectal stricture | KG + DL |
| 38 | eosinophilic gastrointestinal disease | KG + DL |
| 39 | paracetamol poisoning | KG + DL |
| 40 | intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked | KG + DL |
| 41 | intestinal atresia (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.